ORESHACK KURT 4

What Happened
Kurt Oreshack, General Counsel of Maravai Lifesciences (MRVI), sold a total of 50,000 shares in two open‑market transactions: 25,000 shares on 2026-06-09 at $5.06 ($126,500) and 25,000 shares on 2026-06-10 at $5.10 ($127,500), for a combined proceeds of $254,000. These were dispositions (sales), which are often routine and do not necessarily indicate a change in the insider’s view of the company.

Key Details

• Transaction dates & prices: 2026-06-09 — 25,000 shares @ $5.06 ($126,500); 2026-06-10 — 25,000 shares @ $5.10 ($127,500).
• Transaction type: Sale (open-market dispositions).
• Reported under a Rule 10b5‑1 trading plan adopted March 10, 2026 (per filing footnote).
• Filing date: Form 4 filed 2026-06-10 reporting transactions through 2026-06-09; filed within the normal two-business‑day window (not late).
• Shares owned after transaction: not specified in the provided summary—see the full Form 4 for post-transaction holdings.

Context
Because the sales were executed under a pre-established 10b5‑1 plan, they were likely scheduled in advance and are generally viewed as routine insider liquidity rather than a direct signal about company fundamentals. For retail investors, purchases by insiders tend to carry more weight as a bullish signal; sales like these are common and should be interpreted alongside other information.